You are here

Article Text

Article menu
Download PDFPDF
PostScript
Correspondence
The Author's reply
  1. Edward P Gerstenfeld
  1. Correspondence to Dr Edward P Gerstenfeld, Associate Professor of Medicine, University of California, San Francisco, MUE-4th Floor, 500 Parnassus Ave, San Francisco, CA 94143, USA; egerstenfeld{at}medicine.ucsf.edu

https://doi.org/10.1136/heartjnl-2012-301957

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The Author's reply Dr Ward feels that I have given ‘short shrift’ to the cryoballoon in my commentary on the National Institute of Health and Clinical Excellence (NICE) guidelines for laser balloon ablation.1 2 I certainly welcome Dr Wards' comments and summary of cryoballoon efficacy, but feel a few additional comments are necessary.

    First, Dr Ward points out that my comments may be biased because I have a ‘vested interest’ in the laser balloon. It should be noted that while I have received an investigator initiated research grant to perform preclinical work with the laser balloon (as declared in the editorial), I have no other consulting role with the company nor have I received any payment for work with the company. As a physician who spends a large part of my time performing atrial fibrillation …

    View Full Text

    Footnotes

    • Linked article 301956.

    • Competing interests None.

    • Patient consent Obtained.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles